It has burst. The new agreement between Switzerland and the EU will not enter into force. After seven years of negotiations between representatives of the EU Commission and Switzerland, President Guy Parmelin declared the talks a failure yesterday. The reason, he said, was disagreement on crucial points of the negotiations, such as access to the EU’s internal market and agreements on the free movement of persons. The modernisation of the agreement, which has been in place since 1972, has thus failed to materialise.
A failure that particularly affects the Swiss medtech sector shortly after the transition to the new MDR 2017/745. What does this mean for access to the EU internal market?